| Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. | 18042575 | PMC3755272 | Journal | 2007 | 10.1177/1740774507085445 | PEDS-C | | Contributing Study |
| Development Of A Multi-Center, Randomized Controlled Trial For Children With Chronic Hepatitis C (PEDS-C). | | | Journal | 2005 | | PEDS-C | | Contributing Study |
| HCV autoimmunity in a US multi-center cohort of treatment naive children. | | | Journal | 2007 | | PEDS-C | | Contributing Study |
| Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. | 19242286 | PMC2649743 | Journal | 2009 | 10.1097/MPG.0b013e318185998f | PEDS-C | | Contributing Study |
| Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon. | 20512062 | PMC2910798 | Journal | 2010 | 10.1097/MPG.0b013e3181b99cf0 | PEDS-C | | Contributing Study |
| Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. | 18167062 | PMC3755275 | Journal | 2008 | 10.1002/hep.22094 | PEDS-C | | Contributing Study |
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents. | 20400194 | | Journal | 2010 | 10.1016/j.jhep.2010.01.028 | PEDS-C | | Contributing Study |
| The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. | 21036173 | PMC3042126 | Journal | 2011 | 10.1053/j.gastro.2010.10.047 | PEDS-C | | Contributing Study |
